by Motlabur Rahman, Ponkaj K. Datta, Khairul Islam, Mahfuzul Haque, Reaz Mahmud, Uzzwal Mallik, Pratyay Hasan, Manjurul Haque…
A new meta-analysis appears to show that colchicine has no benefit as a treatment for COVID-19, but its inclusion of trials…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
The trial missed its primary endpoint, but an analysis confined to PCR-confirmed infections was more promising.
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
What science has learned works and what doesn’t in COVID treatments A year into treating those with COVID-19, research is…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been…
Автор: 1 минута Колхицин успешно применяется в лечении подагры, ревматологических заболеваний и перикардита.
The gout drug colchicine appears to lower the severity of COVID-19, a small new Brazilian study finds, adding to evidence that…
Publiziert 29. Januar 2021, 16:48 Colchicin – diesen Namen sollte man sich merken: Das Gicht-Medikament scheint das Risiko…
Des comprimés de colchicine Photo: ICM L’une des plus grandes études cliniques réalisées 100% à distance et impliquant des…
Covid-19 can cause dangerous blood clots, but some common drugs could offer a solution.
COVID-19-Splitter Neue Studienergebnisse zu COVID-19: Die „Ärzte Zeitung“ fasst täglich zusammen, was Forscher über das…
COVID-19 therapeutic clinical trials involving off-label, generics and those sponsored by small biotech generally continue to…
COVID-19-Splitter Neue Studienergebnisse zu COVID-19: Heute geht es um Kinder mit COVID-19, den Einsatz von Rekonvaleszenten-Plas…
COVID-19 Zu COVID-19 werden jeden Tag zig Arbeiten publiziert. Manche mit fraglicher Qualität oder unklarer klinischer Relevanz.
Die Herbstzeitlose (Colchicum autumnale) zhlt zu den giftigsten Pflanzen. Sie wird bis zu 30 cm hoch.
medwireNews: Preliminary findings from the GRECCO-19 trial suggest that colchicine, an anti-inflammatory drug used in the…
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for June 2020.
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for June 2020.
Compiled by veteran medical journalist, this roundup of some of the newest science on the COVID-19 pandemic, straight from the…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
What The Study Did: The association between low to moderate alcohol drinking and the rate of age-related decline in cognitive…
新冠肺炎疫情延燒至今，除了疫苗的發展外，藥物的治療仍是刻不容緩，從一開始全球高度關注奎寧類藥物、瑞德西韋等藥物，但實驗結果後發現奎寧類藥物不如預期。如今又出現一項也許對染疫患者有幫助的藥物，是過往用來治療痛風的「秋水仙素」(colchicines)，研究發現…
新冠肺炎疫情延燒至今，除了疫苗的發展外，藥物的治療仍是刻不容緩，從一開始全球高度關注奎寧類藥物、瑞德西韋等藥物，但實驗結果後發現奎寧類藥物不如預期。如今又出現一項也許對染疫患者有幫助的藥物，是過往用來治療痛風的「秋水仙素」(colchicines)，研究發現…
Category: Family Medicine | Infections | Internal Medicine | Critical Care | Emergency Medicine | Nursing | Pharmacy | Journal…
(HealthDay News) -- Hospitalized patients with COVID-19 receiving colchicine have significantly improved time to clinical…
-- Hospitalized patients with COVID-19 receiving colchicine have significantly improved time to clinical deterioration…
As global pharma giants race to find the cure for coronavirus, the use of a 2,000-year-old medicine has shown signs of faster…
What The Study Did: This study examined the worldwide trends of thyroid cancer from 1990 to 2017 according to geographic…
Colchicine-treated patients had longer time to clinical deterioration in GRECCO-19 study Patients hospitalized with Covid-19…
What The Study Did: This observational study looked at the risk of complications after an outpatient colonoscopy among patients…
Infectious Disease > COVID-19 Clinical effects need further investigation, authors urge Hospitalized patients with COVID-19 who…
One more Ebola case reported in newest DRC outbreak One more case has been reported in the latest outbreak in the Democratic…
Colchicine could potentially play a role in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)…
What The Study Did: This randomized clinical trial evaluates the effect of treatment with colchicine on cardiac and…
What The Study Did: The feasibility of using pool testing to identify patients with COVID-19 in a setting with limited testing…